Navigation Links
Labopharm announces pricing of US$20 million public offering of units
Date:2/12/2010

.S. Securities and Exchange Commission and in Canada pursuant to a final short form base shelf prospectus filed with the securities regulatory authorities in each of the provinces of Canada. The offering is being made only by means of a prospectus supplement and accompanying final short form base shelf prospectus. Copies of the prospectus relating to this offering, when available, may be obtained by contacting Deutsche Bank Securities Inc., Attention: Prospectus Department, Harborside Financial Center, 100 Plaza One, Jersey City, New Jersey 07311-3988, telephone: 1-800-503-4611.

This press release does not and shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Labopharm Inc.

Headquartered in Laval, Canada with US offices in Princeton, New Jersey, Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily formulation of tramadol, is now available in 17 countries around the world, including the U.S., Canada, major European markets and Australia. Its second product, OLEPTRO(TM), a novel formulation of trazodone for the treatment of major depressive disorder in adults, has received regulatory approval in the U.S. and is under regulatory review in Canada. Labopharm has initiated the European regulatory approval process for its third product, a twice-daily formulation of
'/>"/>

SOURCE Labopharm Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Labopharm settles $1 million draw down under standby equity distribution agreement
2. Labopharm Initiates Regulatory Approval Process for Twice-Daily Tramadol-Acetaminophen in Europe
3. Labopharm Enters Into CAD$25 Million Standby Equity Distribution Agreement
4. Labopharm Reports Results for Third Quarter Fiscal 2009
5. Labopharm to present data on its novel trazodone formulation at three upcoming international medical meetings
6. Labopharms response for novel trazodone formulation accepted by FDA as complete - Designated as Class 2 resubmission
7. Labopharm submits response to FDA for novel antidepressant
8. Labopharm Reports Results for Second Quarter Fiscal 2009
9. Labopharm to present at Canaccord Adams 29th Annual Global Growth Conference
10. Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET)
11. Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... 2015 , ... Acara Partners, a leading business team in ... complimentary educational webinar series for the summer of 2015. Learn ... clients through targeted marketing, sales, digital communications, branding and business development programs. The ...
(Date:7/6/2015)... Virginia (PRWEB) , ... July 06, 2015 , ... ... choose fat-reduction procedures each year for aesthetic reasons, which is why liposuction regularly ... For a particular demographic, however, fat reduction has become more than a way ...
(Date:7/6/2015)... , ... July 06, 2015 , ... Olive Fertility Centre ... UBC 2014-2015 Post Graduate Teaching Award on behalf of the department of Family Practice. ... very exciting field to be practicing in. The technology is changing so rapidly and ...
(Date:7/6/2015)... ... ... doTERRA, the leading global essential oils company, is pleased to announce the ... position as Director of the Hinckley Institute at the University of Utah, a position ... states that he was ready for a new challenge, and out of many potential ...
(Date:7/6/2015)... ... July 06, 2015 , ... Cancer Hope Network (CHN) ... and medical professionals to chat with the CHN patient services team and connect ... cancer diagnosis is often the most traumatic experience of a person’s life,” said ...
Breaking Medicine News(10 mins):Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 4Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2
... Leaders to Reject Oxygen Funding Reductions,which could ,Jeopardize ... Achieve, Letter Draws Widespread Support Among Home ... Council for Quality,Respiratory Care (CQRC) -- a coalition ... manufacturers who provide care and services to,approximately 650,000 ...
... national No Smoking Day on 12th March by claiming that ... then recent research from the Peninsula Medical School in the ... Extensive research carried out by Dr Iain Lang at the ... psychological wellbeing. Dr Lang and colleagues used a measure of ...
... recycling system: Discarded cellular components, from individual proteins through ... blocks re-used in a different place. The scientific term ... cells, autophagy can also be a form of programmed ... mechanism for complete self-decomposition. , Cancer cells, too, ...
... Philadelphia, PA, March 6, 2008 Surgeons are uniquely ... and to develop innovative solutions to meet those needs. ... lack the know-how to develop their insights into successful ... issue of SURGERY (Volume 143, Number 2, February 2008) ...
... Inc. (OTC Bulletin Board: MLSS), the recognized leader ... month of,February, dentists purchased more units of the ... system for dental,injections, than in any month since ... President of Sales and Marketing at Milestone,stated, "It ...
... Hospital in 25 Years, DENVER, March ... Board: GLOB), an international e-Health, medical,information technology ... has signed an agreement with Mid Coast ... its SafeTrace Tx(R) transfusion,management software. Terms of ...
Cached Medicine News:Health News:Home Oxygen Community Applauds Senator Barbara Mikulski for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicare's Home Oxygen Benefit 2Health News:'Surgery' looks at inventions and innovations by surgeons 2Health News:Milestone Scientific Announces Chicago Dental Society's 143rd Midwinter Meeting Proved Successful 2Health News:Milestone Scientific Announces Chicago Dental Society's 143rd Midwinter Meeting Proved Successful 3Health News:Newest Hospital in New England Signs Agreement With Global Med Technologies(R), Inc. 2Health News:Newest Hospital in New England Signs Agreement With Global Med Technologies(R), Inc. 3
(Date:7/6/2015)... , July 6, 2015   BioClinica®, Inc ... provider, today announced that it has acquired a ... ® , Inc. (Medici).  The acquisition includes affiliates ... LLC.  Medici also provides a lost-to-follow-up patient locate ... globally.  Together with Medici, BioClinica will ...
(Date:7/6/2015)... BEDFORD, Mass. , July 6, 2015 ... the Company plans to release its financial results for ... 29, 2015, after the market closes.  In conjunction with ... day at 4:30 p.m. Eastern Time. Interested ... (in the United States ) or ...
(Date:7/6/2015)... FARMINGTON, Conn. , July 6, ... a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics ... medical need and commercial potential, today announced that ... Series E warrants to purchase 21,917,808 shares of ... purchase 2,191,781 shares of its common stock.  Certain ...
Breaking Medicine Technology:BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2Palatin Technologies Completes $30 Million Financing 2Palatin Technologies Completes $30 Million Financing 3Palatin Technologies Completes $30 Million Financing 4Palatin Technologies Completes $30 Million Financing 5
... 29, 2012 STAAR Surgical Company (NASDAQ: ... implantable lenses for the eye, today announced that it ... the Company,s recent financial results and current business developments ... Company One-on-One Investor Conference will be held on Thursday, ...
... May 29, 2012  Abaxis, Inc. (NasdaqGS: ABAX), a medical ... that Clint Severson, chairman and chief executive officer , ... on Tuesday, June 5, 2012 at 9:00 a.m. ET. ... in New York City. About AbaxisAbaxis ...
Cached Medicine Technology:STAAR Surgical To Present At The Benchmark And Jefferies Investor Conferences 2
... Combines BchiVac V-500 with Vacuum Controller V-800 ... Electronic switching mechanism turns V-500 on and off as ... Model V-500 is a powerful PTFE membrane vacuum pump ... Ideally suited for use with up to two ...
... System UVS400 is a multi-tasking vacuum source ... a refrigerated vapor trap and a maintenance-free, ... unit. The easy-to-use, wide-mouth glass condensation flask ... jar for easy disposal. The UVS400 provides ...
... Vacuum Controller V-800 Efficiently controls vacuum levels ... and off as needed to maintain preset vacuum level ... a powerful PTFE membrane vacuum pump designed to handle ... for use with up to two rotary evaporators ...
Inquire...
Medicine Products: